Non-specific orbital inflammation: Current understanding and unmet needs
- 1 March 2021
- journal article
- review article
- Published by Elsevier in Progress in Retinal and Eye Research
- Vol. 81, 100885
Abstract
No abstract availableKeywords
Funding Information
- National Eye Institute (EY020249, P30 EY 010572)
- Autoimmunity Research
- Stan and Madelle Rosenfeld Family Trust
- William and Mary Bauman Foundation
- Research to Prevent Blindness
This publication has 184 references indexed in Scilit:
- Successful Corticosteroid-Sparing Effect of Rituximab in the Treatment of Refractory Idiopathic Orbital Inflammatory DiseaseCase Reports in Ophthalmology, 2013
- Orbital Pseudotumor—Historical Origin and Modern RelevanceOphthalmic Plastic & Reconstructive Surgery, 2013
- Adalimumab for orbital myositis in a patient with Crohn’s disease who discontinued infliximab: a case report and review of the literatureBMC Gastroenterology, 2013
- Systemic immunoglobulin G4 (IgG4) disease and idiopathic orbital inflammation; removing ‘idiopathic’ from the nomenclature?Eye, 2012
- Rituximab versus Cyclophosphamide for ANCA-Associated VasculitisNew England Journal of Medicine, 2010
- Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactionsClinical and Experimental Immunology, 2010
- Rituximab Treatment of Patients with Severe, Corticosteroid-Resistant Thyroid-Associated OphthalmopathyOphthalmology, 2010
- MR Imaging of Orbital Inflammatory Syndrome, Orbital Cellulitis, and Orbital Lymphoid Lesions: The Role of Diffusion-Weighted ImagingAmerican Journal of Neuroradiology, 2008
- Idiopathic orbital inflammatory syndrome: Clinical features and treatment outcomesBritish Journal of Ophthalmology, 2007
- Management of orbital xanthogranuloma with methotrexateBritish Journal of Ophthalmology, 2006